About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Tuesday, November 25th, 2014

The QualityStocks
Daily Stock List


Greystone Logistics, Inc. (GLGI)

Today we are reporting on Greystone Logistics, Inc. (GLGI), here at the QualityStocks Daily Newsletter.

Tulsa, Oklahoma-headquartered Greystone Logistics, Inc. reprocesses and sells recycled plastic, and designs, manufactures, sells and leases high-quality 100 percent recycled plastic pallets, which provide logistical solutions needed by a wide spectrum of industries. These industries include food and beverage, agricultural, automotive, chemical, as well as pharmaceutical and consumer products. The Company is the largest 100 percent recycled plastic pallet manufacturer in the U.S. OTCQB-listed Greystone Logistics serves beverage, pharmaceutical, and other industries.

The Company’s technology, including that used in its injection molding equipment, and its proprietary blend of recycled plastic resins and patented pallet designs, allows fast production of high-quality pallets and at lower costs than several processes. The recycled plastic for Greystone Logistics’ pallets helps control material costs. This is while decreasing environmental waste. It provides cost advantages over users of virgin resin. The excess plastic not used in the production of pallets undergoes reprocessing for resale.
Concerning procuring or selling resin or excess plastic, Greystone purchases HDPE scrap, pellets, purchings, dust, shavings and parts.  The Company occasionally sells some excess pelletized Santoprene, HDPE and comingled-baled scrap TPU and ABS car bumpers.

Greystone’s products include rackable, nestable, display, monoblock, and stackable pallets. Products also include picture frame web-top pallets and web-top pallets. Additionally, Greystone sells recycled plastic that undergoes reprocessing into pellet form. The Company also provides pallet leasing services.

Greystone offers recycled pallets for sale including full picture frame and three skids models and IBC pallets. Plastic pallets last 10-50 times longer than wood; have residual (trade-in) value; are recyclable; have a high coefficient of friction with anti-skid design for top, bottom, and fork lift tine contact; have considerably lower life cycle costs (cost per trip), and are suited for closed loop systems. Plastic pallets have no exposed nails, wood chips, or broken boards on manufacturing or warehouse floors, which prevents fork lift issues.

Greystone Logistics receives a large portion of its revenue from a national brewer. This customer accounted for roughly 59 percent and 69 percent of the Company’s pallet sales and 51 percent and 69 percent of its’ total sales in fiscal years 2015 and 2014, respectively.

Greystone Logistics, Inc. (GLGI), closed Tuesday's trading session at $0.33, up 6.45%, on 38,500 volume with 14 trades. The average volume for the last 60 days is 29,670 and the stock's 52-week low/high is $0.29/$0.60.

Sangui BioTech International, Inc. (SGBI)

Real Pennies reported previously on Sangui BioTech International, Inc. (SGBI), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Sangui BioTech International, Inc. is a holding company listed on the OTCQB marketplace. The Company’s mission is to provide financing and access to the capital markets for the enterprises of the Sangui group. Sangui BioTech has been a reporting company since 2000. SanguiBioTech GmbH is a 90 percent subsidiary of Sangui BioTech International.

Sangui developed “Granulox”. It is the first dressing to considerably improve oxygen supply to wounds with poor blood supply and thus decisively speeds up wound healing. This month, Sangui BioTech International reported that preclinical trials demonstrate that Sangui hemoglobin preparation improves oxygen supply of vital organs.

A possible success in treating septic shock has been realized by the research team embracing SanguiBioTech GmbH, the Excellence Cluster Cardio Pulmonary System (ECCPS) and TransMIT Gesellschaft für Technologietransfer mbH. Preclinical trials at Giessen University reinforce that a hemoglobin based product developed by SanguiBioTech is apt to improve the oxygen supply of vital organs.

ECCPS is an organization set up jointly by the universities of Frankfurt and Giessen together with the Max Planck Institute for Heart and Lung Research in Bad Nauheim. TransMIT Gesellschaft für Technologietransfer mbH is the unit in charge of technology transfer at Justus-Liebig University in Giessen. TransMIT is involved in carrying out this project.

It is currently being thought that Sangui's hemoglobin-based artificial oxygen carriers may interrupt the self-perpetuating mechanism of septic shock. So far, septic shock has been highly resistant to treatment. Therefore, Sangui's hemoglobin-based artificial oxygen carriers may ultimately reduce the high mortality rates. Preclinical trials in Giessen demonstrate that an oxygen-carrying hemoglobin liquid in the abdomen did substantially improve the oxygen supply to the intestines.

This month, Sangui BioTech International, for the first quarter (as of September 30, 2014) of its 2015 financial year, reported revenues from product sales and royalties of USD73,470 (Q1/2013: USD26,527). This represents an improvement of 73 percent versus Q4 of the prior financial year (as of June 30, 2014).

Sangui BioTech International, Inc. (SGBI), closed Tuesday's trading session at $0.051, down 15.00%, on 56,753 volume with 6 trades. The average volume for the last 60 days is 13,215 and the stock's 52-week low/high is $0.025/$0.28.

New Media Insight Group, Inc. (NMED)

MoneyTV, Pumps and Dumps, PennyStocks24, The Stock Enthusiast, YOLOTraderAlerts, The Trading Report, Todd Horwitz, Trade of the Week, StreetAuthority Financial, and Penny Stock Pinnacle reported earlier on New Media Insight Group, Inc. (NMED), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

New Media Insight Group, Inc. is a leader in mobile payment solutions for small and medium sized businesses (SMB's). It has launched mobile cards - mCards. This is a system that enables merchants to accept mobile payments without any additional hardware other than an existing terminal that takes MasterCard. New Media Insight is employing a grassroots strategy to boost mCards adoption.

The Company is centering its efforts on building alliances with non-profits that already have strong relationships with merchants. New Media Insight Group is based in Cave Creek, Arizona. The Company’s shares trade on the OTCQB.

For Merchants, mCards helps them acquire new customers and reward their loyal customers. For Consumers, mCards are user-friendly, safe, and require no plastic card in one’s wallet. For Non-Profits and Schools, mCards assist in raising new sources of funds and these entities can connect with and support their customer bases.

The Company’s mCards can be created by merchants for their customers, by organizations for their members, by groups for their followers, and by individuals for their family and friends. The "mCard creator" can track the purchases, spend, frequency, visits, marketing message, and communications that happened and led to the end consumer transacting in-store or online.

New Media has its mPAAY. This is an affordable mobile payments, marketing, loyalty and rewards platform that can be set up for merchants quickly. Merchants can begin using mobile rewards, marketing and payments to get more customers spending more money, more often. New Media Insight Group offers three ways (mCards, CloudPay, and Tap to Pay) to accept payments, all with the lowest transaction rates in the nation.

This past July, New Media Insight Group announced that it was in the final development stages of a near field communication (NFC) payment solution. NFC is a sensor driven technology. It permits merchants and customers to conduct the aforementioned "tap-to-pay" transactions, sourced from their mobile devices.

New Media Insight Group, Inc. (NMED), closed Tuesday's trading session at $0.731, down 0.41%, on 81,141 volume with 69 trades. The average volume for the last 60 days is 14,382 and the stock's 52-week low/high is $0.36/$1.77.

Ireland, Inc. (IRLD)

AllPennyStocks, StockEgg, MadPennyStocks, StockRich, PennyInvest, PennyStockVille, BullRally, CoolPennyStocks, and HotOTC reported previously on Ireland, Inc. (IRLD), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Ireland, Inc. is an OTCQB-listed minerals exploration and development company. It targets properties containing large-scale deposits of precious metals in the southwestern United States. The Company incorporated on February 20, 2001 under the laws of the State of Nevada. In February 2008, Ireland acquired its lead project the "Columbus Project.” This is a prospective gold, silver and calcium carbonate property located in Esmeralda County, Nevada. Ireland has its corporate headquarters in Henderson, Nevada.

At the Columbus Project, the Company also has an option to acquire additional adjacent mineral claims. The Columbus Project consists of 466 mineral claims covering around 23,418 acres, plus an additional 80 acres of private land, for a total of 23,498 acres. This includes a 380 acre Permitted Mine Area (60-acre mill site and mill facility, 266-acre mine site with 54 acres defined as "undisturbed area").

The Company’s current permits allows it to mine up to 792,000 tons per year to 40 feet in depth for the purpose of extracting precious metals and calcium carbonate from the Permitted Mine Area. Furthermore, Ireland owns 80 acres of land in the southeast quadrant of the project. The Company’s present exploration efforts are focused on the North and South Sand Zones of the Columbus Project.

The 2,000 acre area of interest that is the focus of Ireland’s present exploration efforts, and that includes the above-mentioned North and South Sand Zones, is situated on what was previously the western side of the Columbus Project site. This area remains well within the boundaries of the claims retained by the Company.

The Columbus project has a mineralized area with considerable historical production of silver in surrounding mountains. Installation of a precious metals leach circuit to the onsite pilot plant has been finished. Upon completion of testing and the optimizing circuit, the Company expects to begin operations.

Ireland terminated its option agreement for the Red Mountain Project in August of this year. The Company abandoned its interest in the mineral claims making up the Red Mountain Project.

Ireland, Inc. (IRLD), closed Tuesday's trading session at $0.175, up 25.00%, on 319,401 volume with 44 trades. The average volume for the last 60 days is 43,255 and the stock's 52-week low/high is $0.11/$0.32.

rVue Holdings, Inc. (RVUE)

TheMicrocapNews, Tiny Gems, MissionIR, SmallCapVoice, AllPennyStocks, and Ceocast News reported earlier on rVue Holdings, Inc. (RVUE), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

rVue Holdings, Inc. is an advertising technology company that lists on the OTC Markets’ OTCQB. The Company provides the digital distribution platform for the Digital Place-Based Advertising industry. Founded in 2009, rVue is an industry expert in planning, buying, as well as delivering Digital Place-Based Media. The Digital Place-Based Media market consists of varied venues and screens adapted to fit their locations. The Company has its corporate headquarters in Elmhurst, Illinois.

rVue Holdings conducts its business via its wholly-owned subsidiary rVue™, Inc. The Company connects approximately one million digital screens across 190 networks. It delivers access to 250 million daily impressions in one simple platform. The Company’s proprietary technology analyzes networks and venues to identify a client’s optimal media plan across a multitude of screens and a host of different networks.

rVue provides its clients’ with a single point of contact and complete service. This includes everything from strategy and planning, to consolidated post-analysis and invoicing. The rVue network database enables the Company to zero in on the DMA, ZIP code or a building that’s most important to reach. The complete selection of available venues is presented. This allows advertisers to target a specific moment in the consumer’s day.

rVue does not own any networks. The Company’s success is grounded on its relationships with Digital Place-Based Media networks. Networks are its partners. rVue provides a high-level view and access to its network partners throughout the country.

Earlier this month, rVue Holdings announced its financial results for the third quarter and year-to-date for the period ended September 30, 2014. Regarding Q3, core revenue grew 123.6 percent to its highest level to date - $248,900 versus $111,300 in the year-ago quarter. Core revenue increased 24.8 percent sequentially versus the $199,500 in Q2 of 2014.

Total revenue grew 90.5 percent to its highest level to date - $280,400 from $147,200 in Q3 2013. Sequentially, total revenue increased 21.4 percent in comparison to the $231,000 in Q2 2014. Net loss for Q3 was $(290,100), or less than one cent per share, an increase of 7.9 percent versus a net loss of $(268,700), or less than one cent per share, in Q3 the year prior.

rVue Holdings, Inc. (RVUE), closed Tuesday's trading session at $0.1299, down 7.15%, on 697,601 volume with 49 trades. The average volume for the last 60 days is 64,296 and the stock's 52-week low/high is $0.0301/$0.165.

Millennium HealthCare, Inc. (MHCC)

PennyStocks24, Stock Onion, Planet Penny Stocks, Buzz Stocks, PennyStockProphet, SecretStockPromo, Penny Pick Finders, TheMicrocapNews, and SmallCapVoice reported on Millennium HealthCare, Inc. (MHCC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Millennium HealthCare, Inc., through its wholly owned operating subsidiaries, provides primary care physician practices, physician groups, and healthcare facilities of all sizes with front-line medical devices focused mainly on preventive care through early detection. The OTCQB-listed Company operates in three segments: Coding, Device, and Vascular.  Millennium HealthCare is headquartered in Garden City, New York.

The Company purchases, supplies, and distributes innovative medical devices and equipment with an emphasis on prevention and early detection. In addition, Millennium HealthCare provides physician practice development, support, and administration services for physician facilities and practices primarily for vascular disorders, including peripheral arterial disease of the lower extremities. Additionally, it offers support and services specializing in medical procedure billing and collections, medical procedure coding, call and message management, and emergency dispatch.   

Millennium HealthCare’s subsidiary, Millennium Medical Devices, signed an exclusive agreement with CDx Diagnostics for distribution of DermCDx™, a brush biopsy test kit used to confirm suspected basal cell carcinoma (BCC).  DermCDx is a minimally invasive test. It combines a patented brush biopsy sampling instrument with computer-assisted three dimensional laboratory analysis.

Millennium HealthCare, through Millennium Medical Devices, has an exclusive agreement with CDx Diagnostics to distribute its OralCDx brush biopsy test kit. OralCDx is a non-invasive test used to test dysplasia (the small white and red tissue spots commonly found in the mouth) to rule out precancerous change. The test has previously been available to dentists nationally. Via this exclusive collaboration, Primary Care Physicians will be able to administer this test to their patients.

Last week, Millennium Healthcare provided details on the Company’s sales and distribution model and an update on Millennium Medical Devices (MMD) as it advances a commercial strategy with efficient use of sales resources and a creative marketing approach. MMD is a wholly owned subsidiary of Millennium Healthcare.

Mr. Dominic Sartorio, Millennium Healthcare Chief Executive Officer, said, "Our third quarter total revenue for the three months ending September 30 was $6.4 million, of which $5.9 million was from the sale of OralCDx® and VasoScan™ diagnostic devices. This is up from the three month total revenue of $0.5 million for the third quarter of 2013, all of which was from physician practice management and other services.”

The design of VasoScan™ is to analyze Autonomic Nervous System (ANS) function, Stress, and Peripheral Blood Circulation. It provides objective data to assist in assessing disorders, including depression, anxiety, sleep disorder, poor concentration, mental/physical stress degree, chronic fatigue, and blood circulation.

Yesterday, Millennium Healthcare announced that it will host a conference call for investors on Tuesday, December 2, 2014 starting at 4:30 p.m. ET. Mr. Dominick Sartorio, and Mr. David Perry, COO will review Q3 2014 and provide a business update.

Millennium HealthCare, Inc. (MHCC), closed Tuesday's trading session at $0.25, down 7.82%, on 302,036 volume with 85 trades. The average volume for the last 60 days is 486,247 and the stock's 52-week low/high is $0.19/$1.50.

AeroGrow International, Inc. (AERO)

OTC Markets Group, StreetAuthority Daily, Greenbackers, and Investor News Source reported earlier on AeroGrow International, Inc. (AERO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

AeroGrow International, Inc.'s primary business is developing, marketing, and distributing advanced indoor aeroponic garden systems. These systems are designed and priced to appeal to the consumer gardening, cooking and small indoor appliance markets globally. AeroGrow started pilot production of its AeroGarden system in December 2005. In March 2006, it commenced shipping these systems to retail and catalogue customers.

Formed as a Nevada corporation on March 25, 2002, AeroGrow International lists on the OTC Markets’ OTCQB. The Company has its headquarters in Boulder, Colorado. On April 23, 2013, AeroGrow International announced that Scotts Miracle-Gro made a $4.5 million equity investment and Intellectual Property (IP) acquisition with the Company. This resulted in a 30 percent beneficial ownership interest in AeroGrow.

The agreement gives AeroGrow the use of the internationally recognized and highly trusted Miracle-Gro brand name. This is while also providing AeroGrow an extensive base of support in marketing, distribution, supply chain logistics, research and development (R&D), as well as sourcing.

AeroGrow International manufactures, distributes and markets seven different models of its AeroGarden systems in multiple colors. It also manufactures, distributes and markets more than 40 varieties of seed pod kits as well as a complete line of accessory products.

The Miracle-Gro AeroGarden line sells through multiple sales channels. These include the Company’s own direct-to -consumer efforts online and by way of proprietary catalogs; wholesale sales through global retailers including Amazon, Costco, The Home Depot and Frontgate Catalog; and international sales via independent distributors.

All Miracle-Gro AeroGardens feature the Company’s proprietary NASA-proven technology. This technology enables consumers to garden indoors, year round, with no dirt and no weeds. Miracle-Gro AeroGardens are complete indoor gardening systems. They feature built in, full spectrum grow lights, patented nutrients, auto-feed, water and lighting systems, and "smart garden" control panels.

This month, AeroGrow International announced results for the quarter ended September 30, 2014, Q2 of its 2015 Fiscal Year.

President and Chief Executive Officer, Mr. J. Michael Wolfe, said, "Second quarter net revenue was up 153 percent to $1.7 million. The biggest driver of this strong revenue trend was our Retail Channel, up 526 percent with a $782,000 increase year over year. This growth was primarily due to increases at existing accounts such as Amazon and Costco.com as well as several newly acquired retail accounts, particularly BJ's Wholesale Club. In addition, our direct-to-consumer channel continued to show strong growth, increasing by 47 percent as sales of both gardens and high margin seed kit and accessories increased to our growing installed base of consumers.”

AeroGrow International, Inc. (AERO), closed Tuesday's trading session at $3.78, down 0.53%, on 6,551 volume with 14 trades. The average volume for the last 60 days is 15,966 and the stock's 52-week low/high is $1.81/$10.45.


The QualityStocks
Company Corner


Pure Hospitality Solutions, Inc. (OTHMD)

The QualityStocks Daily Newsletter would like to spotlight Pure Hospitality Solutions, Inc. (OTHMD). Today, Pure Hospitality Solutions, Inc. closed trading at $0.0082, up 164.62%, on 2,067 volume with 3 trades. The stock’s average daily volume over the past 60 days is 90,732, and its 52-week low/high is $0.0031/$1.0588.

Pure Hospitality Solutions, Inc. announced today, that after reflecting on yesterdays filing of the 3rd quarter disclosures, management feels fairly confident that the Company is on track to deliver significant positive value and become a major player within the Hospitality sector. Management also confirmed that the Company has begun generating revenues from vacation rental bookings at the Bahia Encantada. This income will reflect in the 2014 Year-End report, but has been noted as a subsequent event within this current filing.

Pure Hospitality Solutions, Inc. (OTHMD) is a provider of proprietary technology, marketing solutions, infrastructure and branding services to hotel operators.

The company's innovative platform functions as a powerful vehicle to help hotel operators achieve greater success in three specific areas: (i) expanded international exposure and recognition, (ii) powerful core structure, and (iii) high occupancy rates that drive increases in bottom-line profits. Oriens continuously refines its suite of proprietary solutions to deliver measurable and proven results to hotel properties. This success has been reflected in those properties operating under the Hotel PURE brand as well as with independent boutique hotel properties utilizing the company's Friendly Reservation Online (FROL) booking engine technology and internet marketing services.

Operating a successful bi-lateral business model, Oriens has four objectives:

1. To franchise the Hotel PURE brand to selected hotel properties worldwide similar to the business model currently employed by Big Brand operators such as Holiday Inn, Marriott, Sheraton and others;

2. Provide highly efficient and economical back-end booking engine technology services to independently branded boutique hotels that require a robust online presence;

3. Launch a stand-alone online hotel booking search engine primarily focused on Central America; and,

4. Expand the portfolio of Oriens-owned boutique hotels operating under the Hotel PURE brand.

The company initially began growing its operations primarily in the United States. However most recently, major opportunities in Central America began presenting themselves, giving Oriens the ability to retool its business model. Now the company is positioned to acquire, own and operate its own properties – which would be marketed under the new brand with occupancies handled by the re-launched online booking engine system.

Ultimately, Oriens intends to become a top-tier hotel brand operator and Internet booking and marketing service provider, qualifying as a preferred supplier to lending institutions. The company also intends to establish an invaluable international footprint with its online booking engine technology and marketing offerings; making that segment of its business a prime acquisition target for major online travel search and booking engine companies. Advancement toward this goal is guided by an executive management team with deep expertise in technology, banking, management, hospitality, branding and marketing, technical development and more. Disclaimer

Pure Hospitality Solutions, Inc. Company Blog

Pure Hospitality Solutions, Inc. News:

Pures 3rd Quarter Filing Shows Promise of Increased Positive Value: Revenue and Hard Assets Prove True

Oriens Proudly Completes Reverse Split: Stock Round-Up Preserves Pure Shareholder Participation

Oriens Obtains X-Date to Effectuate Split

Ecrypt Technologies, Inc. (ECRY)

The QualityStocks Daily Newsletter would like to spotlight Ecrypt Technologies, Inc. (ECRY). Today, Ecrypt Technologies, Inc. closed trading at $0.2622, on 5,783,944 volume with 1,203 trades. The stock’s average daily volume over the past 60 days is 615,552 and its 52-week low/high is $0.09/$0.385.

Ecrypt Technologies, Inc. Chief Executive Officer, Dr. Thomas A. Cellucci, and Microsoft Chief Security Officer, Mike Howard, where honored by the Security Industry Association (SIA) with the Jay Hauhn Excellence in Partnerships Award in recognition for their contributions to the security industry. The Jay Hauhn Award will now be presented annually to individuals who strengthen collaboration between the association and industry or end-user organizations.

Ecrypt Technologies, Inc. (ECRY) is an emerging provider of military-strength data security solutions for enterprise, government, and military. The company empowers organizations with the freedom to communicate and collaborate without risk of liability, reputation damage, competitive threat, and other negative outcomes. Ecrypt is the trusted first choice for those looking to keep their communications confidential.

Today’s businesses struggle to guard against the increasing number of dangers as a result of complicated networks built with many different components that are often individually patched to address new threats, while neglecting to close security gaps in traditional solutions. On average, data breaches and subsequent fines and litigation cost a US business $534 million every year, the highest in the world according to the Ponemon Institute.

The flagship Ecrypt solution is an integrated email and encryption server that can be quickly deployed to fortify the security of corporate communication, including attachments and mobile devices, against data breaches while eliminating phishing threats, malware infections, and spam. By using Ecrypt’s paradigm-shifting technology, companies alleviate the need for separate encryption servers with their associated bloated administration and multiple points of weakness.

Ecrypt is well positioned to benefit from increasingly demanding data confidentiality regulations such as the Health Insurance Portability and Accountability Act (HIPAA), the Federal Information Security Management Act (FISMA), and Gramm-Leach-Bliley Act (GLBA). As a result of extensive market research and working directly with organizations in multi-billion dollar industries, the company fully understands the business community’s need to maintain confidentiality, prevent data breaches, comply with government regulations, and mitigate litigation risks. Disclaimer

Ecrypt Technologies, Inc. Blog

Ecrypt Technologies, Inc. News:

Microsoft CSO and Ecrypt CEO Share Inaugural Security Industry Award

Ecrypt's Market Alliance Member, Cicada Security Technology Inc., Announces the Launch of New Data Privacy Products

Ecrypt Technologies Secures Multi-Year Contract With Global High Tech Manufacturer

Boreal Water Collection, Inc. (BRWC)

The QualityStocks Daily Newsletter would like to spotlight Boreal Water Collection, Inc. (BRWC). Today, Boreal Water Collection, Inc. closed trading at $0.004, up 8.11%, on 145,523 volume with 7 trades. The stock’s average daily volume over the past 60 days is 1,244,270, and its 52-week low/high is $0.0032/$0.03.

Boreal Water Collection, Inc. (BRWC) is an established water bottler of premium private-labeled bottled water products tailored for each client’s particular need, be it publicity, promotion, marketing, internal use or a specific event. This emphasis on customization and quality has earned Boreal an impressive reputation, evidenced by its prestigious customer base of high-end beverage brands, retailer channels, high-end hotels and restaurant chains such as H&M, Mercedes, W Hotels, Dean & Deluca, Fred Water, Wat-aah, Saks Fifth Ave, Balance Water, NY Quin Hotel, Bouchon Bakery and Princeton University, just to name a few!

Located 90 miles north New York City, Boreal’s plant is only 17 miles from its well-protected source of natural spring water, a pristine and abundant spring source deep inside the heart of the Catskill Mountains. The spring’s exceptional geological and geographical features have created the perfect environment for Boreal’s low-mineral, sodium-free and well-balanced PH water. With exclusive exploitation rights, Boreal has a confirmed volume in excess of thousands of millions of gallons.

Boreal offers a line of award-winning water products, including functional enhanced water, infused water, carbonated water, vitamins enhanced water, flavored still or sparkling, minerals enhanced water, oxygenated water, electrolyte water, distilled water, alkaline water, caffeinated water and natural spring water.

Accommodating this plentiful water supply and range of product offerings, Boreal has established a 75,000-square foot manufacturing facility. Boreal can process a full range of water and bottle types and has the most creative staff for all private labeling needs. The company offers fully integrated turnkey service, made-to-order labeling along with distinctive water bottles. In short, Boreal is a “Boutique Bottler” and is focusing on becoming the leader of this attractive niche of the growing multi-billion dollar bottled water industry. Disclaimer

Boreal Water Collection, Inc. Company Blog

Boreal Water Collection, Inc. News:

Boreal Water Collection to Exhibit at China's Largest Food Show

Boreal Water Collection Reports Continued Growth in the Third Quarter of 2014, Sales Increase by 14% While Profitability Rises by 57%

The Chatwal Hotel (NY) Agrees to Have Boreal Water Collection Produce Their Private Labeled Bottled Water

Well Power Inc. (WPWR)

The QualityStocks Daily Newsletter would like to spotlight Well Power Inc. (WPWR). Today, Well Power Inc. closed trading at $0.059, up 8.46%, on 76,035 volume with 18 trades. The stock’s average daily volume over the past 60 days is 128,657, and its 52-week low/high is $0.038/$2.00.

Well Power Inc. (WPWR) has secured the licensing rights to Texas with the first right of refusal on the other US states to a new technology solution to process waste natural gas, such as vented, flared or stranded gas, into “clean power” and engineered fuels, including no-sulphur diesel and diluents. Based on proprietary technology, this solution is mobile, high-yield and can be deployed with minimum capital expenditure.

The company plans to be able to provide its technology with full-service engineering, design, construction, modular fabrication, maintenance and construction management services to clients in the upstream areas of exploration and production. Well Power will also offer consulting services, process assessments, facility appraisals, feasibility studies, technology evaluations, project finance structuring and support, and multi-client subscription services.

Approximately 2.4 million barrels of oil equivalent is wasted each day by gas flaring alone, resulting in $10 billion of lost revenue and 400 million metric tons of CO2 equivalent global greenhouse gas emissions each year. Additionally, environmental degradation associated with gas flaring has been shown to have a significant impact on local populations, often resulting in loss of livelihood and severe health issues.

Well Power’s Micro Refinery Unit (MRU) offers the opportunity to create value from a wasted resource while simultaneously enabling wider access to energy, improved environmental conditions, and economic development for local populations. By eliminating legacy flaring and minimizing new flaring, the company is well positioned to take a leadership role in the ongoing push for sustainable resource development and energy efficiency. Disclaimer

Well Power Inc. Company Blog

Well Power Inc. News:

Well Power - Letter from President to Shareholders

Well Power Inc. to host second webinar on proprietory micro-refinery technology

Well Power Inc. Information to be Available through S&P Capital IQ Corporation Records Program

WordLogic Corp. (WLGC)

The QualityStocks Daily Newsletter would like to spotlight WordLogic Corp. (WLGC). Today, WordLogic Corp. closed trading at $0.083, up 3.75%, on 410,000 volume with 14 trades. The stock’s average daily volume over the past 60 days is 45,739, and its 52-week low/high is $0.05/$0.26.

WordLogic Corp. (WLGC) leverages more than 10 years of advanced R&D to assume its position as a global leader in predictive text input technology. Backed by multiple patents and its predictive engine, WordLogic’s interface is revolutionizing the way individuals and businesses search and communicate on touch screen devices. Furthermore, WordLogic offers a range of licensing options of its technology and patent portfolio.

The company’s technology incorporates proprietary Gesturing™ and WordChunking™ features that accelerate typing speeds while reducing the effort needed for accuracy. This interface increased text input on mobile devices by five times, rapidly speeding communication via instant messaging, text messaging, captioning, email and information searching. The iKnowU® keyboard uses state-of-the-art patented technology that becomes more accurate with each use, constantly learning about the user’s style and preferences. Utilizing the WordChunking and Gesturing, iKnowU enables the user to chain together phrases and create whole sentences in a matter of seconds.

For the business realm, WordLogic has developed a unique cloud solution to fit the specific needs of multiple industry sectors, enabling enterprises to create a single cloud-based dictionary specific to the company’s realm of expertise or multiple dictionaries specific for individual specialties or departments. This cloud solution creates continuity for users across multiple devices, boosting accuracy and productivity. WordLogic Reach™ enables users to select and insert meeting plans, contact information, and calendar entries from other apps in the mobile device.

Frost & Sullivan recently recognized WordLogic as the recipient of the 2014 North American Enabling Technology Leadership Award for Predictive Keyboard Applications, saying, “WordLogic’s technically impressive product - WordLogic Predictive Engine and its associated products iKnowU® and Reach™ - offers key competitive advantages, such as market-leading word and phrase prediction capabilities, a context-aware advertising model; simpler integration, increased speed and accuracy; and reduced costs. Add to that the significant number of pending and issued patents and you can see how value a package of technology WordLogic has developed truly is.” Disclaimer

WordLogic Corp. Company Blog

WordLogic Corp. News:

WordLogic (OTCQB:WLGC) Announces that Apple Approves the Launch of an iOS8 Version of the iKnowU Keyboard

WordLogic the Sale of Exclusive Rights to Legal Enterprise Solutions to Private Equity Group

WordLogic Files Patent Infringement Lawsuit Against TouchType Ltd., Makers of SwiftKey

VistaGen Therapeutics, Inc. (VSTA)

The QualityStocks Daily Newsletter would like to spotlight VistaGen Therapeutics, Inc. (VSTA). Today, VistaGen Therapeutics, Inc. closed trading at $10.50, even for the day. The stock’s average daily volume over the past 60 days is 222, and its 52-week low/high is $5.20/$15.00.

VistaGen Therapeutics, Inc. (VSTA) is a biotechnology company applying stem cell technology for drug rescue and cell therapy. Drug rescue combines human stem cell technology with modern medicinal chemistry to generate new chemical variants ("drug rescue variants") of once-promising drug candidates that have been discontinued during late-stage preclinical development due to heart or liver safety concerns. VistaGen also focuses on cell therapy, or regenerative medicine, which includes repairing, replacing or restoring damaged tissues or organs

VistaGen's versatile stem cell technology platform, Human Clinical Trials in a Test Tube™, has been developed to provide clinically relevant predictions of potential heart and liver toxicity of promising new drug candidates long before they are ever tested on humans.

By more closely approximating human biology than conventional animal studies and other nonclinical techniques and technologies currently used in drug development, VistaGen's human stem cell-based bioassay systems can improve the predictability of the drug development cycle and lower the cost of new drug research and development by identifying product failures earlier in the cost curve. According to the Food and Drug Administration even only a ten percent improvement in predicting failure before clinical trials could save $100 million in development costs, which savings ultimately could be passed on to patients.

Using mature human heart cells produced from stem cells, VistaGen has developed and internally validated CardioSafe 3D™, a novel three-dimensional (3D) bioassay system for predicting the in vivo cardiac effects of new drug candidates before they are tested in humans. VistaGen is now focused on using CardioSafe 3D™ to generate up to two new, safer small molecule drug rescue variants every twelve to eighteen months. VistaGen anticipates that these drug rescue variants will be modified versions of once-promising new drug candidates that have been discontinued by pharmaceutical companies and academic research institutions because of heart toxicity concerns, despite substantial prior investment and positive efficacy data demonstrating their potential therapeutic and commercial benefits. In most cases, VistaGen plans to license or sell its new, safer drug rescue variants in strategic partnering arrangements with global pharmaceutical companies, arrangements providing VistaGen with both near term and downstream milestone payments and economic participation rights but without future development cost obligations.

AV-101, VistaGen's lead small molecule prodrug candidate, has successfully completed Phase I clinical development in the U.S. for treatment of neuropathic pain, a serious and chronic condition affecting millions of people worldwide, depression, and other neurological diseases and conditions. To date, the U.S. National Institutes of Health (NIH) has awarded VistaGen over $8.75 million for development of AV-101. Management anticipates strategically out-licensing AV-101 to a development and marketing partner in 2013.

VistaGen is also developing LiverSafe 3D™, a novel predictive liver toxicity and drug metabolism bioassay system for drug rescue applications. In parallel with drug rescue activities, the Company is funding early-stage nonclinical studies focused on potential cell therapy applications of its Human Clinical Trials in a Test Tube™ platform. Disclaimer

VistaGen Therapeutics, Inc. Company Blog

VistaGen Therapeutics, Inc. News:

VistaGen Signs Letter of Intent With National Institute of Mental Health for NIH-Sponsored Phase 2 Clinical Study of AV-101 in Major Depressive Disorder

VistaGen Receives Notice of Allowance for Canadian Patent, Further Expanding Stem Cell Technology Platform

VistaGen Announces Reverse Stock Split

Consorteum Holdings, Inc. (CSRH)

The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH). Today, Consorteum Holdings, Inc. closed trading at $0.004, even for the day. The stock’s average daily volume over the past 60 days is 111,747, and its 52-week low/high is $0.0031/$0.019.

Consorteum Holdings, Inc. (CSRH) has spent the last 3 years developing relationships and licensing agreements to take the center stage in the emerging market of mobile gaming. The company has the capability to deliver rich mobile content to end users who will use their smart phones in ways that could not even have been imagined five years ago.

Specializing in delivery of mobile content, mobile payment solutions and products through a mix of on-deck partnerships, license agreements, and joint venture revenue share arrangements, the company operates as a technology and services aggregator to meet the diverse needs of its client base. This approach enables unparalleled flexibility when sourcing solutions, resulting in smarter, faster deployment of technologies, competitive pricing, and potential for new streams of revenue.

ThreeFiftyNine Inc., a wholly owned subsidiary, hired a software development team that had previously designed the world’s first regulatory compliant mobile platform for delivery of gaming content created by a third party. The platform, which has met the rigorous standards of the Nevada Gaming Board, the gold standard in regulatory gaming, represents the first generation software delivery platform for mobile devices. The development team spent the past 5 years and millions of dollars in non-recurring engineering costs to complete the development of the platform. At the heart is the capability to deliver any digital content across any cellular network to any mobile device. This key differentiator makes it possible for Consorteum to approach many different markets that are in the business of providing mobile connectivity and mobile content.

Consorteum’s mobile initiatives will benefit multiple business verticals. The company has strategically designed its business initiatives to create repetitive transactions on an ongoing basis. Consorteum's goal is to have their customers think of them more as partners, rather than just technology providers, for longer-lasting, more profitable relationships. Disclaimer

Consorteum Holdings, Inc. Company Blog

Consorteum Holdings, Inc. News:

Consorteum Holdings Signs License Agreement With NYG Holdings

Consorteum Holdings Signs Mobile Application Development Contract With Bet Butler Limited

Consorteum Holdings Launches New Mobile Results App for Popular Keno Game


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters





Stock Analyzer


FatCat Stocks

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251